Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-11

Clinical Trial Update: Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating DEXTENZA for pain and inflammation in non-infectious anterior uveitis compared with standard topical corticosteroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)

Snippet

Sponsor: New England Retina Associates | Conditions: Non-infectious Anterior Uveitis | Phase 4 | Status: UNKNOWN